Oral Cephalexin Population Pharmacokinetics and Target Attainment Analysis in Infants 7-60 Days Old
Andrew S. Haynes(Children's Hospital Colorado), Peter L. Anderson(University of Colorado Denver), Charles A. Peloquin(University of Florida), Kevin Messacar(University of Colorado Anschutz Medical Campus), Daniel González(University of North Carolina at Chapel Hill), Douglas N. Fish(University of Montana), Marc H. Scheetz(Midwestern University), Zixuan Wei(University of Montana), Sonya Tang Girdwood(Cincinnati Children's Hospital Medical Center)
Cited by 1
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody
|JAMA Neurology|2018|373
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
Defining success with HIV pre-exposure prophylaxis
|AIDS|2015|324